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Abstract
The creation of microbial cell factories for sustainable production of natural products is important for medical and indus-
trial applications. This requires stable expression of biosynthetic pathways in a host organism with favorable fermentation 
properties such as Bacillus subtilis. The aim of this study is to construct B. subtilis strains that produce valuable terpenoid 
compounds by overexpressing the innate methylerythritol phosphate (MEP) pathway. A synthetic operon allowing the con-
certed and regulated expression of multiple genes was developed. Up to 8 genes have been combined in this operon and a 
stably inherited plasmid-based vector was constructed resulting in a high production of  C30 carotenoids. For this, two vec-
tors were examined, one with rolling circle replication and another with theta replication. Theta-replication constructs were 
clearly superior in structural and segregational stability compared to rolling circle constructs. A strain overexpressing all 
eight genes of the MEP pathway on a theta-replicating plasmid clearly produced the highest level of carotenoids. The level 
of transcription for each gene in the operon was similar as RT-qPCR analysis indicated. Hence, that corresponding strain 
can be used as a stable cell factory for production of terpenoids. This is the first report of merging and stably expressing this 
large-size operon (eight genes) from a plasmid-based system in B. subtilis enabling high  C30 carotenoid production.
Keywords Bacillus subtilis · MEP · Carotenoids · Cell factory · Stability
Introduction
Bacillus subtilis is a gram-positive bacterium that is consid-
ered as a GRAS (generally regarded as safe) organism by 
the Food and Drug Administration (FDA). The bacterium 
possesses properties that render it suitable for metabolic 
engineering to develop it as a cell factory, such as its fast 
growth rate and capability to grow on cheap raw material 
like molasses [22, 23]. B. subtilis also has a broad metabolic 
potential, no significant bias in codon usage and a wide sub-
strate range. Hence, it is suitable for expression of diverse 
kinds of proteins allowing B. subtilis to be engineered to 
produce a multitude of metabolites including riboflavin [3, 
17, 34].
Terpenoids are considered as one of the metabolite groups 
that are important in pharmaceutical, food, and cosmetic 
industries. Different terpenoids have been exploited as food 
colorants, fragrances or drugs such as the antimalarial arte-
misinin and anticancer paclitaxel [1, 8, 37]. High demand 
for medicinal terpenoids and the low yield of isolation from 
their natural sources warrant an alternative supply strat-
egy [2, 6]. Microbial terpenoid cell factories have become 
one of the alternative choices in fulfilling the gap between 
demand and supply of these metabolites [2, 20]. Terpenoids 
are produced through two generic pathways called methyl 
erythritol phosphate (MEP) and mevalonate (MVA) path-
way. B. subtilis has an innate MEP pathway (Fig. 1) with 
the capability to produce higher isoprene amounts compared 
to most eubacteria including E. coli [13]. Thus, it has the 
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prospective to be engineered for high productivity of ter-
penoids. Further improvement of B. subtilis terpenoid pro-
duction capability requires multigene overexpression of the 
MEP pathway enzymes. Tightly regulated overexpression of 
the MEP pathway genes is required to overcome toxicity due 
to intermediate product accumulation such as dimethylallyl 
diphosphate (DMAPP), isopentenyl diphosphate (IPP), and 
farnesyl diphosphate (FPP) at the beginning of the bacte-
rium growth phase [26]. This regulation can be achieved 
using inducible promoters [5, 9]. Furthermore, there are also 
efforts to develop genetic manipulation tools of B. subtilis, 
particularly at the genomic level [7, 31, 33]. Nevertheless, 
for practical reasons and multicopy gene amplification abil-
ity, plasmids are still a choice for protein overexpression. 
In addition, endogenous genes of MEP pathway are spread 
on multiple locations under different regulatory elements 
in the B. subtilis genome [10]. Hence, constructing a single 
synthetic operon of MEP pathway genes under the control of 
an inducible promoter in a stable replicative plasmid would 
be beneficial.
Closest prior art on metabolic engineering of B. subtilis 
involving an operon of multiple genes contained only two 
genes in a rolling circle plasmid without having the sta-
bility data and manipulation on ribosome binding site to 
optimize the protein expression [40]. However, the stabil-
ity of these rolling circle replication plasmids is usually 
poor prohibiting the scale up to fermentation status [4, 18, 
25]. Hence, the need for a stable expression system in B. 
subtilis allowing the construction of plasmids with large 
inserts encompassing multiple genes is a pressing issue.
In this paper, we aim to bring together all of the endog-
enous MEP pathway genes in a regulated synthetic operon 
on a single plasmid facilitating high precursor supply for 
 C30 terpenoid production. The validity of this approach is 
demonstrated by an unprecedented high production of  C30 
terpenoids by the concerted overexpression of the whole 
MEP pathway of B. subtilis. This system can serve as a 
basis for using B. subtilis as a cell factory for various com-
mercially important terpenoids.
Fig. 1  2-C-methyl-d-erythritol-4-phosphate (MEP) pathway
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Materials and methods
Bacterial strains, growth conditions and vectors
Bacterial strains and expression vectors used in this research 
are listed in Table S1. Growth conditions are similar to our 
previous study [37].
Cloning strategy
Genes encoding dxs, ispD, ispH, ispF, ispC, ispE, ispG and 
ispA were amplified from B. subtilis genomic DNA, based 
on published annotation of its genome, using PCR with 
the suitable primers available in our previous study [37]. 
In our previous study, we were able to construct operons 
containing up to four genes of MEP pathway in pHCMC04G 
designated as SDFH (containing dxs-ispD-ispF-ispH), and 
CEGA (ispC-ispE-ispG-ispA) operons. To create the pHC-
MC04G construct containing seven genes of MEP pathway 
along with ispA gene, responsible for producing farnesyl 
pyrophosphate, the CEGA subset was amplified using prim-
ers (F-CEGA and R-CEGA as in Table S2 Supplementary 
Materials) that introduce overlapping flanks with the BglII-
restricted p04SDFH construct. Subsequently, the CEGA was 
inserted to the restricted p04SDFH using circular polymer-
ase extension cloning (CPEC) [21], resulting in p04SDFH-
CEGA (Fig. S1).
Expression of the genes from the different 
constructs in B. subtilis 168
With his-tag sequence at the last protein of the operon, we 
could check the expression of the respective protein before 
the downstream addition of another gene. B. subtilis 168 
strains with pHB201 and pHCMC04G constructs were cul-
tured then followed by preparation and detection of protein 
samples as previously published [37].
Real‑time quantitative PCR (RT‑qPCR) analysis
Bacillus subtilis 168 strain p04SDFHCEGA was incubated 
as described under 2.3. After induction with xylose, the cul-
ture was incubated further for 5 h and harvested for total 
RNA isolation. The total RNA was extracted from the pellet 
using  Maxwell® 16 LEV simplyRNA Purification Kit with 
an additional enzymatic digestion step. The reverse tran-
scription reaction was then performed immediately using 
Moloney Murine Leukemia Virus Reverse Transcriptase 
(M-MLV RT, Promega) together with random primer (Pro-
mega) to synthesize cDNA. The thermal program was: incu-
bate for 10 min at 20 °C, 60 min at 37 °C, 12 min at 20 °C, 
5 min at 99 °C, and then keep the program at 4 °C. cDNA 
was used in qPCR immediately, or stored at − 20 °C until 
use.
Transcriptional level of target genes was analyzed by RT-
qPCR with SYBR Green (SensiMix™ SYBR Low-ROX kit, 
Bioline) in QuantStudio™ 7 Flex Real-Time PCR System 
(Thermo Fisher Scientific). Each sample was measured 
in triplicate. The thermal cycling program was: 95 °C for 
10 min, 40 cycles of 95 °C for 15 s, 60 °C for 25 s, and 
followed by melting curve analysis using the defaulted pro-
gram. Data analysis was carried out using QuantStudio™ 
Real-Time PCR Software v1.3 (Thermo Fisher Scientific). 
The p04SDFHCEGA plasmid was used to construct standard 
curves for quantitative analysis. The logarithmic of absolute 
copy number of each target part was interpolated from the 
standard curves. Primers were designed using NCBI Primer-
BLAST online (https ://www.ncbi.nlm.nih.gov/tools /prime 
r-blast /) [39]. The primers were designed to overlap between 
two genes at the beginning, middle and end of the operon 
and thus not to react with non-episomal genes. Hence, the 
primers used overlap as follows, between genes dxs and 
ispD (SD), between genes ispH and ispC (HC), and between 
genes ispG and ispA (GA), respectively.
Analysis of segregational and structural stability 
of the constructs in B. subtilis 168
Segregational stability was measured by evaluating the 
growth of B. subtilis 168 cells harboring the p201SDFH, 
p201CEGA, p04SDFH, p04CEGA or p04SDFHCEGA con-
structs in TSB medium for 100 generations in the absence 
of antibiotics.
The cells of B. subtilis 168 were first grown in 1-ml TSB 
broth containing 5 μg/ml chloramphenicol for 16 h at 37 °C. 
The overnight cultures were inoculated into 10-ml fresh TSB 
broth without chloramphenicol and incubated at 37 °C, 
220 rpm for 24 h, attaining full growth. The cultures were 
diluted 1:1000 by fresh TSB broth without chloramphenicol 
and further incubated for 12 h (growth of 1:1000 dilution 
accounts for about 10 generations of cultivation,  210 = 1024). 
These cultures were diluted  106 fold and plated onto LB agar 
plates without chloramphenicol. After incubation at 37 °C 
overnight, 160 colonies were picked up and transferred onto 
LB agar plate supplemented with 5 μg/ml chlorampheni-
col. This treatment, starting from 1:1000 culture dilution 
followed by plating, was successively repeated 10 times to 
obtain 100 generations of cultivation. The presence of the 
plasmids was confirmed by the growth of the colonies on 
the plates, thus indicating that the plasmid hosted by the 
colonies is segregationally stable. The segregational stability 
of each construct was represented as % of colonies retain-
ing the plasmid construct which is equal to [colonies on LB 
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plate with antibiotic/colonies on LB plate without antibiotic 
× 100%].
Structural stability of the constructs was determined as 
described above apart from the addition of chlorampheni-
col throughout the cultivation then colony PCR was used 
to detect large fragment deletions, in addition to random 
sequencing to detect mutations and small fragment dele-
tions. Colony PCR was conducted using a pair of sequencing 
primers (Table S2) attached to the upstream and downstream 
of the operon of p201 and p04 constructs. The amplicons 
were then subjected to gel agarose electrophoresis to detect 
any large fragment deletions when a band smaller than the 
expected size was observed on the gel.
Production of carotenoids in B. subtilis strains 
overexpressing MEP pathway genes
The B. subtilis strains containing both pHB201 and pHC-
MC04G constructs of MEP pathway genes were transformed 
with the pHYCrtMN plasmid, bearing genes responsible 
for carotenoid production. The genes were expressed, and 
carotenoids were extracted and quantified as described in a 
previous study [37].
Nucleotide sequence accession number
The nucleotide sequence of the complete genome of Bacillus 
subtilis 168 is reported with the following accession num-
bers: AL009126 and NC000964. The MEP pathway genes 
used in this study were amplified from the genomic DNA 
of B. subtilis 168.
Results and discussion
Constructing synthetic operons harboring MEP 
pathway genes
The cloning strategy reported here allowed the insertion of 
multiple genes into a single synthetic operon controlled by 
the same promotor. Two vectors with different promoters 
and mode of replication were compared. pHB201 rolling 
circle replication vector with the P59 constitutive promotor 
and pHCMC04G theta-replication vector with xylose induc-
ible promotor. The constructed operons contained genes of 
the MEP pathway starting from one gene up to eight genes 
(Table S3). It also permitted to insert before each gene the 
B. subtilis mntA ribosomal binding site, which is considered 
as a strong Shine-Dalgarno sequence (ΔG > 50.4 kJ mol−1). 
A spacing of six nucleotides to the starting codon was 
employed to ensure translational efficiency [32]. The pres-
ence of a C-terminal his-tag code at the end of the operon 
made it possible to purify the terminal protein encoded by 
each operon and evaluate its expression on Western blot 
using anti-his antibodies (Fig. 2a). This strategy allowed 
for consecutive insertion of genes where the expression 
of each inserted gene is confirmed before adding the next 
gene. All genes in each operon were checked by sequencing 
demonstrating that all transcripts are intact. Current cloning 
strategy involving CPEC method allowed us to put together 
seven genes of MEP pathway in addition to ispA into a theta-
replicating plasmid.
Study of p04SDFHCEGA operon expression using 
RT‑qPCR analysis
The p04SDFHCEGA strain contains eight genes in the same 
operon regulated by a single promotor. RT-qPCR analysis 
was used to confirm equal expression level of all genes in 
the operon. Since the B. subtilis genome contains a copy of 
each of the MEP pathway genes, using primers specific for 
Fig. 2  a Western blot of pHCMC04G constructs of MEP pathway 
proteins expressed in B. subtilis 168. Proteins were isolated from B. 
subtilis 168 cell lysates and purified using His SpinTrap™ columns 
(GE Healthcare). After purification, protein samples were loaded 
on an SDS-gel and detected on Western blot using specific antibody 
against the his-tag. Volume of the samples was adjusted according to 
the concentration of each sample measured by nanodrop spectropho-
tometer for 40 μg of total protein. Dxs (70 kDa); IspD (26 kDa); IspF 
(17  kDa); IspH (35  kDa); IspC (43  kDa); IspE (32  kDa); IspG (41 
kD); IspA (32 kDa). The differences in intensities of the bands maybe 
influenced by the differences in availability of the his-tag for Spin-
Trap™ and antibody binding. The proteins are all translated from the 
same transcript using the same RBS. b Expression level of genes in 
B. subtilis 168 containing p04SDFHCEGA construct. The expression 
level of each target fragment was represented as the logarithmic of 
absolute copy number per unit input total cDNA (10 ng), quantified 
by qPCR using serial dilutions of standards. SD represents beginning 
of the operon, fragment containing overlap of genes dxs and ispD; 
HC depicts middle of the operon, fragment containing overlap of 
genes ispH and ispC; GA illustrates end of the operon, fragment con-
taining overlap of genes ispG and ispA. Mean values of three inde-
pendent experiments with standard deviation are indicated by error 
bars
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each gene would not differentiate between the expression 
levels of the chromosomal and plasmid genes. Hence, prim-
ers overlapping at sequences between two genes at the begin-
ning (SD), middle (HC) and end (GA) of the operon were 
designed to avoid amplifying the chromosomal genes. This 
is indeed confirmed by the absence of any signal in the wild-
type strain. The expression level of each target fragment is 
represented as the logarithm of absolute copy number per 
unit input total cDNA. The level of expression of the genes 
at the beginning, middle and end of the p04SDFHCEGA 
operon was nearly similar (Fig. 2b) indicating that the single 
promotor was effective in controlling the expression of the 
entire operon in pHCMC04G vector. The results show that 
the transcripts are intact and all genes are expressed at the 
same level irrespective of their position in the operon. This 
can eliminate any doubt about the effect of the long length 
of the operon on the integrity of the mRNA transcripts and 
in turn, on protein expression.
Segregational and structural stability 
of the constructed plasmids in B. subtilis 168
After the successful compilation of the operons, a com-
parison between the pHB201 and pHCMC04G constructs 
was made investigating their segregational and structural 
stability in B. subtilis 168. The pHCMC04G strains show 
approximately 100% ability to retain the plasmid construct 
in medium without antibiotic until the 40th generation after 
which a slight loss of the plasmid occurred (Fig. 3). The 
plasmids showed over 85% stability inheritance until the 
100th generation. In contrast, the strains with rolling circle 
plasmid pHB201 showed significant loss starting from the 
20th generation ending with more than 70% plasmid loss 
by the 100th generation. Sequencing of the pHCMC04G 
constructs indicated that 100%, 88% and 90% of the colo-
nies of p04SDFH, p04CEGA and p04SDFHCEGA strains, 
respectively, possessed the correct sequence of the operon 
after 100 generations indicating their structural stabil-
ity. In contrast, the sequences of the constructed operons 
in pHB201 usually showed deletions and mutations when 
the plasmid size became more than 10 kb based on colony 
pcr and sequencing performed. Sequencing results showed 
that already after the 10th generation only 57% and 62% of 
the colonies of p201SDFH and p201CEGA strains, respec-
tively, had the correct sequence. Note that, the creation of 
a pHB201 eight gene construct turned out to be impossible 
further proving the segregational and structural instability 
of the pHB201 constructs.
These results are in line with the facts that rolling circle 
replication plasmids usually suffer from structural insta-
bility where recombination of short direct repeats present 
within this single-stranded DNA may lead to the deletions 
[12, 18, 24]. In addition, pHB201 is a plasmid that lacks 
active partitioning during replication which makes it prone 
to segregational instability causing loss of the entire plasmid 
population from a cell. It is noteworthy to mention that the 
instability of pHB201 is also observed independent of the 
use of a strong constitutive promotor, as pHB201 showed the 
same pattern of instability when a xylose promotor was used. 
It has been described that more stable plasmids might be 
derived on the basis of theta-replication mechanisms, origi-
nated from large plasmid of gram-positive bacteria such as 
pAMβ1 from Streptococcus faecalis, pTB52 from thermo-
philic Bacillus, and also pLS20 and pLS32 from B. subtilis 
natto [11, 19, 28–30]. Theta-replication-based plasmids are 
mostly low-copy number plasmids that replicate in the host 
through a theta-type intermediate where two replication 
forks proceed independently around the DNA ring; hence, 
they are structurally and segregationally stable up to a size 
of 50 kb compared to rolling circle replication plasmids in 
which nucleic acid replication is unidirectional leading to 
instability [15, 19, 24, 27]. Our results are fully in line with 
these findings as we show that even a metabolically very 
active synthetic operon can be stably maintained.
Enhanced carotenoid production in B. subtilis strains 
overexpressing MEP pathway genes
The  OD600 of all MEP pathway engineered B. subtilis strains 
after 24-h growth ranged from  OD600 7–9. The total amount 
of carotenoids, 4,4′-diaponeurosporene and 4,4′-diapoly-
copene, produced in the different B. subtilis strains over-
expressing MEP pathway genes with the help of pHB201 
or pHCMC04G constructs was calculated as (mg/g dcw) 
to allow comparison between the strains. As a control, B. 
subtilis strain that only contains the pHYCrtMN plasmid 
Fig. 3  Segregational stability of pHB201 and pHCMC04G constructs 
in B. subtilis 168. The stability of strains was represented as the % of 
colonies retaining the plasmid formed on the chloramphenicol-con-
taining plates after successive subculturing (100 generations) from 
three different independent cultures
248 Journal of Industrial Microbiology & Biotechnology (2020) 47:243–249
1 3
was used. The amount of total carotenoids produced in the 
B. subtilis strains containing pHB201 constructs overex-
pressing MEP pathway genes is less than that produced by 
the strains containing pHCMC04G constructs by approxi-
mately 50% (Fig. 4); this is in accordance with the decreased 
stability of the pHB201 constructs compared to the pHC-
MC04G constructs. The pHCMC04G strain overexpressing 
the eight genes, dxs, ispD, ispH, ispF, ispC, ispE, ispG, and 
ispA showed the highest amount of carotenoids produced, 
approximately 21 mg/g dcw, around 20-fold higher than the 
control strain with only pHYCrtMN plasmid. This amount 
of  C30 carotenoids produced has never been reported before. 
The production level in B. subtilis can compete with produc-
tion of  C40 carotenoids such as lycopene reported in E. coli 
at 7.55 mg/g dcw [42] and at 24.41 mg/g dcw in Saccha-
romyces cerevisiae [35], β-carotene at 20.79 mg/g dcw in 
S. cerevisiae [36], zeaxanthin at 11.95 mg/g dcw in E. coli 
[14] or astaxanthin at 8.64 mg/g dcw in E. coli [16] and at 
8.10 mg/g dcw in S. cerevisiae [41]. In addition, the reported 
production level in the eight gene B. subtilis strain is higher 
than that reported for other terpenoids in B. subtilis such as 
0.5 mg/L of isoprene [38] and 17 mg/L of amorphadiene 
[40].
Conclusion
A B. subtilis strain overexpressing the whole MEP path-
way (p04SDFHCEGA) in a stable manner was success-
fully created. This is the first report of the expression of 
the complete MEP pathway in a plasmid-based system in 
B. subtilis where it was proven that such a large operon can 
be stably expressed. This strain significantly improved the 
production of  C30 carotenoids in B. subtilis. Together with its 
GRAS status, that E. coli does not possess, and fast growth 
rate, this could make B. subtilis a preferable cell factory 
for the production of different valuable terpenoids such as 
artemisinin and paclitaxel at the industrial level.
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